Lisa M Shackelton (L M Shackelton)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Top Venues

Alimentary pharmacology & therapeutics

Inflammatory bowel diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Florian Rieders, Christopher Ma, Jurij Hanžel, Joel G Fletcher, Mark E Baker, Zhongya Wang, Leonardo Guizzetti, Lisa M Shackelton, Julie Rémillard, Mihir Patel, Jiafei Niu, Ronald Ottichilo, Cynthia S Santillan, Nunzia Capozzi, Stuart A Taylor, David Henry Bruining, Guangyong Zou, Brian G Feagan, Vipul Jairath, Jordi Rimola, null null
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Florian Rieders, Christopher Ma, Jurij Hanžel, Joel G Fletcher, Mark E Baker, Zhongya Wang, Leonardo Guizzetti, Lisa M Shackelton, Julie Rémillard, Mihir Patel, Jiafei Niu, Ronald Ottichilo, Cynthia S Santillan, Nunzia Capozzi, Stuart A Taylor, David Henry Bruining, Guangyong Zou, Brian G Feagan, Vipul Jairath, Jordi Rimola, null null
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Florian Rieders, Christopher Ma, Jurij Hanžel, Joel G Fletcher, Mark E Baker, Zhongya Wang, Leonardo Guizzetti, Lisa M Shackelton, Julie Rémillard, Mihir Patel, Jiafei Niu, Ronald Ottichilo, Cynthia S Santillan, Nunzia Capozzi, Stuart A Taylor, David Henry Bruining, Guangyong Zou, Brian G Feagan, Vipul Jairath, Jordi Rimola, null null
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease. Radiology 312 (2) (2024)
Sudheer Kumar Vuyyuru, Lisa M Shackelton, Jurij Hanžel, Christopher Ma, Vipul Jairath, Brian G Feagan
Targeting IL-23 for IBD: Rationale and Progress to Date. Drugs (2023)
Eileen Crowley, Christopher Ma, Leonard Guizzetti, Guangyong Zou, Peter J Lewindon, Michael S Gee, Jeffrey S Hyams, Michael J Rosen, Daniel von Allmen, Anthony de Buck van Overstraeten, Lisa M Shackelton, Julie Remillard, Lauren Schleicher, Jonathan R Dillman, Jordi Rimola, Stuart A Taylor, Joel G Fletcher, Peter C Church, Brian G Feagan, Anne M Griffiths, Vipul Jairath, Mary-Louise C Greer
Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials. Inflammatory bowel diseases (2023)
Rocio Sedano, Christopher Ma, Rish K Pai, Geert D' Haens, Leonardo Guizzetti, Lisa M Shackelton, Julie Remillard, Paolo Gionchetti, Ilyssa O Gordon, Stefan Holubar, Maia Kayal, Gregory Y Lauwers, Reetesh K Pai, Darrell S Pardi, Mark A Samaan, David F Schaeffer, Bo Shen, Mark S Silverberg, Brian G Feagan, William J Sandborn, Vipul Jairath
An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials. Alimentary pharmacology & therapeutics 53 (10) (2021)
Gregor Novak, Toer W Stevens, Tanja Van Viegen, Peter Bossuyt, Borut Štabuc, Jenny Jeyarajah, Guangyong Zou, Ingrid C Gaemers, Trevor D McKee, Fred Fu, Lisa M Shackelton, Reena Khanna, Gijs R van den Brink, William J Sandborn, Brian G Feagan, Rish K Pai, Vipul Jairath, Niels Vande Casteele, Geert D'Haens
Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease. Alimentary pharmacology & therapeutics 49 (11) (2019)
M J Warners, C A Ambarus, A J Bredenoord, J Verheij, G Y Lauwers, J C Walsh, David A Katzka, S Nelson, T van Viegen, G T Furuta, S K Gupta, L Stitt, G Zou, C E Parker, Lisa M Shackelton, G R D Haens, W J Sandborn, E S Dellon, Brian G Feagan, M H Collins, Vipul Jairath, Rish K Pai
Reliability of histologic assessment in patients with eosinophilic oesophagitis. Alimentary pharmacology & therapeutics 47 (7) (2018)
M A Samaan, C A J Puylaert, B G Levesque, G Y Zou, L Stitt, S A Taylor, Lisa M Shackelton, M K Vandervoort, R Khanna, C Santillan, J Rimola, P Hindryckx, C Y Nio, W J Sandborn, G D'Haens, Brian G Feagan, Vipul Jairath, J Stoker
The development of a magnetic resonance imaging index for fistulising Crohn's disease. Alimentary pharmacology & therapeutics 46 (5) (2017)
G R D'Haens, W J Sandborn, G Zou, L W Stitt, P J Rutgeerts, D Gilgen, V Jairath, P Hindryckx, Lisa M Shackelton, M K Vandervoort, C E Parker, C Muller, R K Pai, O Levchenko, Y Marakhouski, M Horynski, E Mikhailova, N Kharchenko, S Pimanov, Brian G Feagan
Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis. Alimentary pharmacology & therapeutics 46 (3) (2017)